The first shipment of iron ore from the massive Simandou project in Guinea arrived at a Chinese port on Jan. 17. It would be “highly challenging” for Guinea’s massive Simandou iron ore project to meet its target of reaching full production within 30 months, a leading industry analyst said, citing infrastructure bottlenecks. The project has a designed annual capacity of 120 million tons. Its first ...
The first shipment of iron ore from the massive Simandou project in Guinea arrived at a Chinese port on Jan. 17. It would be “highly challenging” for Guinea’s massive Simandou iron ore project to meet its target of reaching full production within 30 months, a leading industry analyst said, citing infrastructure bottlenecks. The project has a designed annual capacity of 120 million tons. Its first shipment of 200,000 tons of high-grade ore arrived at a Chinese port on Jan. 17 after a 46-day voyage. Beyond that initial cargo, progress at Simandou has been limited, with delays already emerging, Erik Hedborg, principal analyst at U.K.-based commodities consultancy CRU, told Caixin in a December interview.
The US Food and Drug Administration rejected a subcutaneous version of AstraZeneca Plc ’s lupus medicine that would make it easier to administer. Astra provided the information requested in the FDA’s complete response letter, the UK drugmaker said Tuesday . It will work with the regulator and said it still hopes to progress the application as quickly as possible. The medicine, Saphnelo, is already...
The US Food and Drug Administration rejected a subcutaneous version of AstraZeneca Plc ’s lupus medicine that would make it easier to administer. Astra provided the information requested in the FDA’s complete response letter, the UK drugmaker said Tuesday . It will work with the regulator and said it still hopes to progress the application as quickly as possible. The medicine, Saphnelo, is already approved as an intravenous treatment, meaning it has to be injected in a vein rather than just under the skin, which patients can do themselves. Analysts estimate the drug could garner more than $1.6 billion in annual revenue by 2031, according to Bloomberg data. Saphnelo is prescribed to treat lupus, a disease where the immune system attacks healthy tissue in the body. Over 3.4 million people are affected worldwide, according to Astra. The European Union approved the subcutaneous administration of Saphnelo in December . A late stage trial of a self-administered injection of Saphnelo showed that the drug helped to reduce disease severity compared with a placebo. The FDA is expected to decide on the updated application in the first half of this year. In the interim, the intravenous version of the medicine remains available.
Key Points Certain retirement accounts -- such as traditional IRAs -- feature required minimum distributions (RMDs). You have some options when it comes to taking your first one. Your decision could save you some money -- or cost you some. The $23,760 Social Security bonus most retirees completely overlook › If you're not familiar with required minimum distributions (RMDs) and their rules, it coul...
Key Points Certain retirement accounts -- such as traditional IRAs -- feature required minimum distributions (RMDs). You have some options when it comes to taking your first one. Your decision could save you some money -- or cost you some. The $23,760 Social Security bonus most retirees completely overlook › If you're not familiar with required minimum distributions (RMDs) and their rules, it could cost you a lot. It's smart to get savvy about RMDs, even if your retirement is years away. Here's a brief introduction to RMDs and some thoughts on when you might want to take your first one. It's worth reading, even if you're not turning 73 this year. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Required minimum distribution basics Most of us would do well to make the most of tax-advantaged retirement accounts -- such as individual retirement accounts (IRAs) and 401(k)s -- as we save and invest for retirement. But with certain such accounts, you'll be expected -- nay, required -- to take required minimum distributions. RMDs are required to be taken annually from accounts such as traditional IRAs, SEP IRAs, and SIMPLE IRAs once you reach the age of 73. (Roth accounts don't feature RMDs for the original owners of the accounts.) When you take your RMD, that income will count as taxable income -- so plan for it when you're developing your retirement plan. Important: When to take your first RMD If you're turning 73 in 2026 or soon after, take note: You have until April 1 of the year after you turn 73 to take your first RMD. After that, though, the deadlines fall on Dec. 31. Your second RMD will be due on Dec. 31 of the year in which you turn 74. Here, then, are three key options, assuming you're turning 73 in 2026: You could take your first RMD in 2026 and your second in 2027. You could take your first RMD by April 1, 2027 and your second by Dec. 31, 20...
Indonesian Finance Minister Purbaya Yudhi Sadewa said a warning about corporate transparency from MSCI Inc. last week, which triggered a slump in local stocks, represents an opportunity for an economy which he defended as fundamentally robust. The MSCI warning “is a good thing,” Purbaya said in an interview with Bloomberg TVs Haslinda Amin in a business forum on Tuesday in Jakarta. He said last we...
Indonesian Finance Minister Purbaya Yudhi Sadewa said a warning about corporate transparency from MSCI Inc. last week, which triggered a slump in local stocks, represents an opportunity for an economy which he defended as fundamentally robust. The MSCI warning “is a good thing,” Purbaya said in an interview with Bloomberg TVs Haslinda Amin in a business forum on Tuesday in Jakarta. He said last week’s market decline represented jitters in the market, not a meltdown, and joked that once investors realize he is in charge, sentiment will improve. “If we improve the transparency, we will remove the disease in our market, which at the end will help improve our economic condition,” Purbaya said at the Indonesia Economic Summit. MSCI last week warned that long-standing investability concerns could result in the emerging market being downgraded to frontier status if reforms are not delivered by May. The warning triggered a sharp selloff that briefly erased tens of billions of dollars in market value, forced trading halts and prompted heavy foreign selling.
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
Boastful CEO Alex Karp said it’s a “massive acceleration in growth, a cosmic reward.” 🚀 Numbers Go Brrr, Karp Goes Cosmic CEO Alex Karp summed it up in classic Karp fashion, calling the results a “massive acceleration in growth” and a “cosmic reward.” Modest? No. Effective? Apparently yes. Shares jumped about 7% after hours as investors digested a quarter that combined explosive growth with real p...
Boastful CEO Alex Karp said it’s a “massive acceleration in growth, a cosmic reward.” 🚀 Numbers Go Brrr, Karp Goes Cosmic CEO Alex Karp summed it up in classic Karp fashion, calling the results a “massive acceleration in growth” and a “cosmic reward.” Modest? No. Effective? Apparently yes. Shares jumped about 7% after hours as investors digested a quarter that combined explosive growth with real profitability, a rare combo in AI-adjacent land. Growth with margins tends to get Wall Street’s attention fast. smashed expectations for the fourt quarter, posting $1.4 billion in revenue, up 70% year over year, versus $1.3 billion expected. Adjusted EPS landed at $0.25, beating estimates and nearly doubling last year’s result. 🧠 US Demand Is Doing the Heavy Lifting International sales grew a slower 22%, still positive but highlighting that Palantir’s growth story remains very US-centric for now. Government revenue also pulled its weight, rising 66% to $570 million. Combined, US quarterly revenue cleared $1 billion for the first time, a psychological and financial milestone. US revenue surged 93%, with commercial sales up 137% to $507 million. Translation: private companies are opening their wallets for Palantir’s AI-driven data platforms, not just government agencies. 💰 Profits, Cash, and Big Guidance Energy Palantir posted a 41% operating margin in Q4 and converted 47% of 2025 revenue into free cash flow. That’s real money, not adjusted optimism. The company now sits on over $7 billion in cash and marketable securities. Management also raised Q1 and full-year 2026 guidance well above analyst expectations, signaling confidence that demand is not a one-quarter wonder.
India's aviation regulator had also ordered an investigation of cockpit fuel switches in Boeing 787 and Boeing 737 aircraft operating in the country after the crash. Air India had said then that its inspections did not find any issue with the locking mechanism of the switch, which it reiterated on Monday.
India's aviation regulator had also ordered an investigation of cockpit fuel switches in Boeing 787 and Boeing 737 aircraft operating in the country after the crash. Air India had said then that its inspections did not find any issue with the locking mechanism of the switch, which it reiterated on Monday.